INOCA: Non-Invasive Assessment of the Pathophysological Mechanisms Using CZT-SPECT MAGALI

pp. 185-192

Authors

  • Magali Y. Gobbo Médico en Sección Medicina y Cardiología Nuclear, Instituto cardiovascular de Buenos Aires (ICBA) https://orcid.org/0000-0003-4900-4160
  • Alejandro H. Meretta Médico en Sección Medicina y Cardiología Nuclear, Instituto cardiovascular de Buenos Aires (ICBA)-MTSAC
  • María Sciancalepore Médico en sección Ultrasonido Cardiovascular, Instituto cardiovascular de Buenos Aires (ICBA)
  • Erica Retamozo Técnica en medicina nuclear
  • Estefania Beber Técnica en medicina nuclear-Técnica en prácticas cardiológicas
  • Daniel Rosa Médico en Sección Medicina y Cardiología Nuclear, Instituto cardiovascular de Buenos Aires (ICBA)
  • Néstor Pérez Baliño Médico en Sección Medicina y Cardiología Nuclear, Instituto cardiovascular de Buenos Aires (ICBA)-MTSAC
  • Osvaldo H. Masoli Médico en Sección Medicina y Cardiología Nuclear, Instituto cardiovascular de Buenos Aires (ICBA)-MTSAC https://orcid.org/0000-0003-2496-6216

DOI:

https://doi.org/10.7775/rac.v90i3.108

Keywords:

Microvascular blood flow - Vascular endothelium - Vascular smooth muscle-SPECT

Abstract

Background: One of the causes of INOCA (Ischemia with Non- Obstructive Coronary Arteries) is microvascular dysfunction
(MVD), which can be noninvasively assessed through the quantification of myocardial blood flow (MBF) and myocardial
flow reserve (MFR). 
Dynamic myocardial perfusion imaging (MPI) by CZT-SPECT at rest, with dipyridamole stress test and cold pressor test
(CPT) can establish the presence of two different pathophysiological mechanisms of MVD: endothelium-independent or
endothelium-dependent, respectively.
Objectives: The aim of this study was to evaluate the usefulness of CZT-SPECT for the diagnosis of MVD and the different
mechanisms involved in patients with INOCA.
Materials and Methods: A total of 93 consecutive INOCA patients were prospectively included and underwent dynamic
MPI with CZT-SPECT at rest and with dipyridamole stress test and CPT. THe MBF was quantified using 4DM® software. A
MFR response to dipyridamole <2, and changes in MBF (ΔMBF) <1.5 with CPT were considered abnormal responses. MVD
was defined in the presence of one abnormal response or both.
Results: CZT-SPECT detected MVD in 85% (n=79) of the patients with INOCA. Forty-two percent had an abnormal response
to both stressors while 43% presented an abnormal response of MBF only with CPT.
Conclusion: The use of CZT-SPECT with both stress tests allowed the evaluation of different possible pathophysiological
mechanisms of MVD present in most patients with INOCA.

Published

2022-06-30

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)

1 2 3 > >>